5/7
10:19 am
rhhby
Think Bioscience extends Seed Round to accelerate pocket-finding platform [Yahoo! Finance]
Low
Report
Think Bioscience extends Seed Round to accelerate pocket-finding platform [Yahoo! Finance]
5/7
09:24 am
rhhby
Sapient Appoints Jonathan Usuka as Chief Business Officer [Yahoo! Finance]
Low
Report
Sapient Appoints Jonathan Usuka as Chief Business Officer [Yahoo! Finance]
5/7
07:39 am
rhhby
Enable Injections Expands Strategic Partnership with Roche [Yahoo! Finance]
Low
Report
Enable Injections Expands Strategic Partnership with Roche [Yahoo! Finance]
5/7
01:08 am
rhhby
Galderma Receives Filing Acceptances for Nemolizumab in Prurigo Nodularis and Atopic Dermatitis in Four Additional Countries [Yahoo! Finance]
Low
Report
Galderma Receives Filing Acceptances for Nemolizumab in Prurigo Nodularis and Atopic Dermatitis in Four Additional Countries [Yahoo! Finance]
5/6
08:13 am
rhhby
OpRegen® (RG6501) Phase 1/2a Clinical Study 24-Month Visual Acuity Results Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit [Yahoo! Finance]
Low
Report
OpRegen® (RG6501) Phase 1/2a Clinical Study 24-Month Visual Acuity Results Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit [Yahoo! Finance]
5/2
07:44 am
rhhby
Investors in Roche Holding (VTX:ROG) have unfortunately lost 18% over the last three years [Yahoo! Finance]
Low
Report
Investors in Roche Holding (VTX:ROG) have unfortunately lost 18% over the last three years [Yahoo! Finance]
4/29
12:05 pm
rhhby
Managing Total Cost of Care is a Top Goal but Access to Reliable Data is Challenging, the Latest Trends in Specialty Drug Benefits Report by Pharmaceutical Strategies Group (PSG) Found [Yahoo! Finance]
Low
Report
Managing Total Cost of Care is a Top Goal but Access to Reliable Data is Challenging, the Latest Trends in Specialty Drug Benefits Report by Pharmaceutical Strategies Group (PSG) Found [Yahoo! Finance]
4/29
08:10 am
rhhby
Accord BioPharma, Inc. Announces U.S. Food & Drug Administration Approval of HERCESSI™ (trastuzumab-strf), a biosimilar to Herceptin® (trastuzumab) for the Treatment of Several Forms of HER2-Overexpressing Cancer [Yahoo! Finance]
Low
Report
Accord BioPharma, Inc. Announces U.S. Food & Drug Administration Approval of HERCESSI™ (trastuzumab-strf), a biosimilar to Herceptin® (trastuzumab) for the Treatment of Several Forms of HER2-Overexpressing Cancer [Yahoo! Finance]
4/29
08:10 am
rhhby
Bonum Therapeutics to Present on its Novel Platform for Generating Conditionally Activated Targeted Therapies at Keystone Conference [Yahoo! Finance]
Low
Report
Bonum Therapeutics to Present on its Novel Platform for Generating Conditionally Activated Targeted Therapies at Keystone Conference [Yahoo! Finance]
4/29
07:13 am
rhhby
Alentis Appoints Alberto Toso Chief Scientific Officer [Yahoo! Finance]
Low
Report
Alentis Appoints Alberto Toso Chief Scientific Officer [Yahoo! Finance]
4/25
01:32 pm
rhhby
AI for drug discovery draws a $1 billion launch—and a lot of hope [Yahoo! Finance]
Low
Report
AI for drug discovery draws a $1 billion launch—and a lot of hope [Yahoo! Finance]
4/25
11:23 am
rhhby
AI for drug discovery draws a $1 billion launch—and a lot of hope [Fortune]
Low
Report
AI for drug discovery draws a $1 billion launch—and a lot of hope [Fortune]
4/24
08:38 pm
rhhby
Xaira, an AI drug discovery startup, launches with a massive $1B, says it's ‘ready' to start developing drugs [TechCrunch]
Low
Report
Xaira, an AI drug discovery startup, launches with a massive $1B, says it's ‘ready' to start developing drugs [TechCrunch]
4/24
10:26 am
rhhby
Roche (RHHBY) Q1 Hit by Currency Headwinds, Lower COVID-19 Sales [Yahoo! Finance]
Low
Report
Roche (RHHBY) Q1 Hit by Currency Headwinds, Lower COVID-19 Sales [Yahoo! Finance]
4/24
09:12 am
rhhby
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
4/24
05:13 am
rhhby
Swiss pharmaceutical maker Roche says group sales dropped 6% [Yahoo! Finance]
Low
Report
Swiss pharmaceutical maker Roche says group sales dropped 6% [Yahoo! Finance]
4/24
04:09 am
rhhby
Affimed Announces Acceptance of AFM24 Clinical Abstract at the 2024 Annual Meeting of the American Society of Clinical Oncology [Yahoo! Finance]
Low
Report
Affimed Announces Acceptance of AFM24 Clinical Abstract at the 2024 Annual Meeting of the American Society of Clinical Oncology [Yahoo! Finance]
4/24
01:59 am
rhhby
Swiss pharma giant Roche's first-quarter sales edge higher as its emerges from post-Covid-19 slump [CNBC]
Low
Report
Swiss pharma giant Roche's first-quarter sales edge higher as its emerges from post-Covid-19 slump [CNBC]
4/24
01:15 am
rhhby
[Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 2% (CER) in first quarter with both divisions growing in high single digit ex COVID-19 [Yahoo! Finance]
Low
Report
[Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 2% (CER) in first quarter with both divisions growing in high single digit ex COVID-19 [Yahoo! Finance]
4/23
08:12 am
rhhby
Health Canada authorizes Tecentriq® SC (atezolizumab, solution for subcutaneous injection), the first cancer immunotherapy subcutaneous injection, for multiple cancer types [Yahoo! Finance]
Low
Report
Health Canada authorizes Tecentriq® SC (atezolizumab, solution for subcutaneous injection), the first cancer immunotherapy subcutaneous injection, for multiple cancer types [Yahoo! Finance]
4/23
08:00 am
rhhby
Health Canada authorizes Tecentriq® SC (atezolizumab, solution for subcutaneous injection), the first cancer immunotherapy subcutaneous injection, for multiple cancer types
Low
Report
Health Canada authorizes Tecentriq® SC (atezolizumab, solution for subcutaneous injection), the first cancer immunotherapy subcutaneous injection, for multiple cancer types
4/19
04:30 pm
rhhby
FDA Roundup: April 19, 2024 [Yahoo! Finance]
Medium
Report
FDA Roundup: April 19, 2024 [Yahoo! Finance]
4/19
12:14 pm
rhhby
Roche (RHHBY) Alecensa Wins FDA Nod for Label Expansion [Yahoo! Finance]
Low
Report
Roche (RHHBY) Alecensa Wins FDA Nod for Label Expansion [Yahoo! Finance]
4/19
01:03 am
rhhby
Nykode Therapeutics Initiates Phase 2 Trial of VB10.16 in Second Line HPV16-Positive Cervical Cancer [Yahoo! Finance]
Low
Report
Nykode Therapeutics Initiates Phase 2 Trial of VB10.16 in Second Line HPV16-Positive Cervical Cancer [Yahoo! Finance]
4/19
01:03 am
rhhby
FDA approves Roche's Alecensa as the first adjuvant treatment for people with ALK-positive early-stage lung cancer [Yahoo! Finance]
Low
Report
FDA approves Roche's Alecensa as the first adjuvant treatment for people with ALK-positive early-stage lung cancer [Yahoo! Finance]